Kelsey Goodwin
Stock Analyst at Piper Sandler
(0.86)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SMMT Summit Therapeutics | Initiates Coverage On: Neutral | 21 | 28.23 | -25.61% | 1 | Aug 19, 2025 | |
JANX Janux Therapeutics | Initiates Coverage On: Overweight | 42 | 22.68 | 85.19% | 1 | Aug 19, 2025 | |
RVMD Revolution Medicines | Initiates Coverage On: Overweight | 75 | 34.71 | 116.08% | 1 | Aug 19, 2025 | |
URGN UroGen Pharma | Initiates Coverage On: Overweight | 36 | 18.27 | 97.04% | 4 | Aug 19, 2025 | |
CGON CG Oncology | Initiates Coverage On: Overweight | 55 | 23.91 | 130.03% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 11 | 6.42 | 71.34% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 112 | 74.98 | 49.37% | 3 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 36 | 9.95 | 261.81% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | n/a | n/a | n/a | 3 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | 3.28 | 143.9% | 1 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | n/a | n/a | n/a | 3 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Oct 31, 2022 |